Jana Kordulakova

Dr. Jana Kordulakova

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2012 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
AGAnna E Grzegorzewicz
Anna E Grzegorzewicz
HPHa Pham
Ha Pham
VGVijay A K B Gundi
Vijay A K B Gundi
MSMichael S Scherman
Michael S Scherman
ENElton J North
Elton J North
MJMary Jackson
Mary Jackson
An adamantyl urea derivative identified as a potent bactericidal compound against Mycobacterium species and multidrug-resistant M. tuberculosis targets a late step in biogenesis of very-long-chain cell wall–bound mycolic acids—by inhibiting the transport of the fatty acids across the bacterial plasma membrane. New chemotherapeutics active against multidrug-resistant Mycobacterium tuberculosis are urgently needed. We report on the identification of an adamantyl urea compound that shows potent bactericidal activity against M. tuberculosis and a unique mode of action, namely the abolition of the translocation of mycolic acids from the cytoplasm, where they are synthesized to the periplasmic side of the plasma membrane and are in turn transferred onto cell wall arabinogalactan or used in the formation of virulence-associated, outer membrane, trehalose-containing glycolipids. Whole-genome sequencing of spontaneous-resistant mutants of M. tuberculosis selected in vitro followed by genetic validation experiments revealed that our prototype inhibitor targets the inner membrane transporter MmpL3. Conditional gene expression of mmpL3 in mycobacteria and analysis of inhibitor-treated cells validate MmpL3 as essential for mycobacterial growth and support the involvement of this transporter in the translocation of trehalose monomycolate across the plasma membrane.

29 April 2015 in ACS Chemical Biology
Verified
Journal Article
Closed access
MBMiroslav Brecik
Miroslav Brecik
ICIvana Centárová
Ivana Centárová
RMRaju Mukherjee
Raju Mukherjee
GKGaëlle S. Kolly
Gaëlle S. Kolly
SHStanislav Huszár
Stanislav Huszár
KMKatarína Mikušová
Katarína Mikušová

27 February 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GDGiulia Degiacomi
Giulia Degiacomi
ABAndrej Benjak
Andrej Benjak
JMJan Madacki
Jan Madacki
FBFrancesca Boldrin
Francesca Boldrin
RPRoberta Provvedi
Roberta Provvedi
Riccardo ManganelliRiccardo Manganelli
Riccardo Manganelli
MmpL3 is an inner membrane transporter of Mycobacterium tuberculosis responsible for the export of trehalose momomycolate, a precursor of the mycobacterial outer membrane component trehalose dimycolate (TDM), as well as mycolic acids bound to arabinogalactan. MmpL3 represents an emerging target for tuberculosis therapy. In this paper, we describe the construction and characterization of an mmpL3 knockdown strain of M. tuberculosis. Downregulation of mmpL3 led to a stop in bacterial division and rapid cell death, preceded by the accumulation of TDM precursors. MmpL3 was also shown to be essential for growth in monocyte-derived human macrophages. Using RNA-seq we also found that MmpL3 depletion caused up-regulation of 47 genes and down-regulation of 23 genes (at least 3-fold change and false discovery rate ≤1%). Several genes related to osmoprotection and metal homeostasis were induced, while several genes related to energy production and mycolic acids biosynthesis were repressed suggesting that inability to synthesize a correct outer membrane leads to changes in cellular permeability and a metabolic downshift.

1 October 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MGMarcelo E. Guerin
Marcelo E. Guerin
JKJana Kordulakova
Jana Kordulakova
PAPedro M. Alzari
Pedro M. Alzari
PBPatrick J. Brennan
Patrick J. Brennan
MJMary Jackson
Mary Jackson
Phosphatidyl-myo-inositol mannosides (PIMs) are unique glycolipids found in abundant quantities in the inner and outer membranes of the cell envelope of all Mycobacterium species. They are based on a phosphatidyl-myo-inositol lipid anchor carrying one to six mannose residues and up to four acyl chains. PIMs are considered not only essential structural components of the cell envelope but also the structural basis of the lipoglycans (lipomannan and lipoarabinomannan), all important molecules implicated in host-pathogen interactions in the course of tuberculosis and leprosy. Although the chemical structure of PIMs is now well established, knowledge of the enzymes and sequential events leading to their biosynthesis and regulation is still incomplete. Recent advances in the identification of key proteins involved in PIM biogenesis and the determination of the three-dimensional structures of the essential phosphatidyl-myo-inositol mannosyltransferase PimA and the lipoprotein LpqW have led to important insights into the molecular basis of this pathway.

1 November 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AGAnna E. Grzegorzewicz
Anna E. Grzegorzewicz
JKJana Kordulakova
Jana Kordulakova
VJVictoria Jones
Victoria Jones
SBSarah E. M. Born
Sarah E. M. Born
Juan BelardinelliJuan Belardinelli
Juan Belardinelli
MJMary Jackson
Mary Jackson
Isoxyl (ISO) and thiacetazone (TAC), two prodrugs once used in the clinical treatment of tuberculosis, have long been thought to abolish Mycobacterium tuberculosis (M. tuberculosis) growth through the inhibition of mycolic acid biosynthesis, but their respective targets in this pathway have remained elusive. Here we show that treating M. tuberculosis with ISO or TAC results in both cases in the accumulation of 3-hydroxy C18, C20, and C22 fatty acids, suggestive of an inhibition of the dehydratase step of the fatty-acid synthase type II elongation cycle. Consistently, overexpression of the essential hadABC genes encoding the (3R)-hydroxyacyl-acyl carrier protein dehydratases resulted in more than a 16- and 80-fold increase in the resistance of M. tuberculosis to ISO and TAC, respectively. A missense mutation in the hadA gene of spontaneous ISO- and TAC-resistant mutants was sufficient to confer upon M. tuberculosis high level resistance to both drugs. Other mutations found in hypersusceptible or resistant M. tuberculosis and Mycobacterium kansasii isolates mapped to hadC. Mutations affecting the non-essential mycolic acid methyltransferases MmaA4 and MmaA2 were also found in M. tuberculosis spontaneous ISO- and TAC-resistant mutants. That MmaA4, at least, participates in the activation of the two prodrugs as proposed earlier is not supported by our biochemical evidence. Instead and in light of the known interactions of both MmaA4 and MmaA2 with HadAB and HadBC, we propose that mutations affecting these enzymes may impact the binding of ISO and TAC to the dehydratases.

1 September 2011 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
JBJoshua R. Brown
Joshua R. Brown
ENElton J. North
Elton J. North
JHJulian G. Hurdle
Julian G. Hurdle
CMChristophe Morisseau
Christophe Morisseau
JSJerrod S. Scarborough
Jerrod S. Scarborough
RLRichard E. Lee
Richard E. Lee